Skip to main content
PRIMR23 SBER23 Main banner
Icon Legend
Presentation Icons
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
Livestreaming Session Icon
Livestreaming Session Icon
Live Session Recorded
Live Session Recorded
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Call for Session Proposal
Call for Session Proposal
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back
View Video

2023 PRIM&R Annual Conference

Pharma/Biotech Perspectives

Emerging Research Challenges and Breaking Issues

D16 - [IN-PERSON/RECORDED] FDA Modernization Act 2.0: Fact and Fiction

Tuesday, December 5, 2023
1:00 PM – 2:00 PM ET
Location: Room 206
Live Session Recorded IACUC/Animal Care and Use Deep Dive Series
This session will be offered in-person and recorded for on-demand access by in-person PRIMR23 attendees registered for this day, and PRIMR23/SBER23 Virtual Meeting registrants.

In 2022, the FDA Modernization Act 2.0 was passed. The media immediately began reporting "No more animals needed for drug discovery and development!" Is this accurate? In this session, we will separate fact from fiction and examine our current and future state in regards to when and where animals will be needed when developing new medicines.

Learning Objectives:

  • Learn what was changed in with the passing of the FDA Modernization Act 2.0
  • Discuss where the field is with alternatives for developing and testing new drugs
  • Explore where nonhuman animal models are still needed, why, and the value they bring to the scientific process